← back to search

Dalin Li

Harbin Medical University · CN
🔎 Find collaborators in Oncology · Cancer Research →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Oncology · Cancer Research
Research interest
Research focused on Breast cancer and Single-nucleotide polymorphism, with related work in Haplotype, Genotype, Gene knockdown. Notable publications include 'PD-1/PD-L1 interaction up-regulates MDR1/P-gp expression in breast cancer cells via PI3K/AKT and MAPK/ERK pathways', 'lncRNA LCPAT1 Upregulation Promotes Breast Cancer Progression via Enhancing MFAP2 Transcription', and 'Circulating cell-free DNA-based methylation patterns for breast cancer diagnosis'.
h-index
citations
478
works
19
NIH funding
primary concept
email

Recent publications

Integrating ctDNA Dynamics and Sequential Organoid Drug Screening Enhances Breast Cancer Treatment Efficacy
Cancer Research 2025cited by 3position: middledoi
Mendelian Randomization Assessment of the Genetic Effects of Lipid‐Lowering Drugs on Digestive System Cancers
Food Science & Nutrition 2025cited by 1position: lastdoi
An Approach for Differential Diagnosis of Breast Tumors by <scp>ctDNA</scp> Methylation Sequencing
Cancer Medicine 2025cited by 1position: middledoi
Cross-modal deep learning model for predicting pathologic complete response to neoadjuvant chemotherapy in breast cancer
npj Precision Oncology 2024cited by 19position: lastdoi
Quality of Life in Patients with Breast Cancer following Breast Conservation Surgery: A Systematic Review and Meta-Analysis
Journal of Healthcare Engineering 2022cited by 16position: middledoi
Circulating cell-free DNA-based methylation patterns for breast cancer diagnosis
npj Breast Cancer 2021cited by 46position: middledoi
Effective Disease Control After Combinatorial Treatment with a PD-1 Antibody and an mTOR Inhibitor for Recurrent Ovarian Clear Cell Carcinomas: A Case Report and Literature Review
OncoTargets and Therapy 2021cited by 6position: lastdoi
lncRNA LCPAT1 Upregulation Promotes Breast Cancer Progression via Enhancing MFAP2 Transcription
Molecular Therapy — Nucleic Acids 2020cited by 49position: lastdoi
Human epidermal growth factor receptor 2-positive metastatic breast cancer with novel epidermal growth factor receptor -ZNF880 fusion and epidermal growth factor receptor E114K mutations effectively treated with pyrotinib
Medicine 2020cited by 10position: lastdoi
PD-1/PD-L1 interaction up-regulates MDR1/P-gp expression in breast cancer cells via PI3K/AKT and MAPK/ERK pathways
Oncotarget 2017cited by 109position: lastdoi
Androgen Receptor Expression and Bicalutamide Antagonize Androgen Receptor Inhibit β-Catenin Transcription Complex in Estrogen Receptor-Negative Breast Cancer
Cellular Physiology and Biochemistry 2017cited by 44position: middledoi
B7-H4 expression in human infiltrating ductal carcinoma-associated macrophages
Molecular Medicine Reports 2016cited by 26position: middledoi
A case-control study about the association between vascular endothelial growth inhibitor gene polymorphisms and breast cancer risk in female patients in Northeast China
Chinese Journal of Cancer Research 2016cited by 8position: middledoi
DcR3 gene polymorphisms are associated with sporadic breast infiltrating ductal carcinoma in Northeast Chinese women
Oncotarget 2016cited by 4position: middledoi
Association of TNF-α, TNFRSF1A and TNFRSF1B Gene Polymorphisms with the Risk of Sporadic Breast Cancer in Northeast Chinese Han Women
PLoS ONE 2014cited by 43position: middledoi
HVEM Gene Polymorphisms Are Associated with Sporadic Breast Cancer in Chinese Women
PLoS ONE 2013cited by 16position: firstdoi
Association of CTLA-4 gene polymorphisms with sporadic breast cancer risk and clinical features in Han women of Northeast China
Molecular and Cellular Biochemistry 2012cited by 38position: firstdoi
Association of OX40L Polymorphisms with Sporadic Breast Cancer in Northeast Chinese Han Population
PLoS ONE 2012cited by 20position: middledoi
Investigation of CD28 Gene Polymorphisms in Patients with Sporadic Breast Cancer in a Chinese Han Population in Northeast China
PLoS ONE 2012cited by 19position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Dianjun Li · Harbin Medical University8 papers (2012–2017)Zhenkun Fu · Harbin Medical University8 papers (2012–2016)Da Pang · First People's Hospital of Foshan8 papers (2012–2025)Weiguang Yuan · Harbin Medical University8 papers (2012–2025)Shuang Chen · Shihezi University5 papers (2012–2017)Fengyan Xu · Harbin Medical University5 papers (2012–2016)Yongdong Jiang · Harbin Medical University3 papers (2017–2025)Shaoli Han · Harbin Medical University3 papers (2014–2016)Yanhong Liu · Harbin Medical University2 papers (2012–2013)Shihui Yu · Seattle Children's Hospital2 papers (2021–2025)Xianyu Zhang · Hebei Medical University2 papers (2021–2025)Xiaoshuan Liang · Harbin Medical University2 papers (2017–2020)Yanni Song · Houston Methodist2 papers (2017–2025)Tonghui Ma · Nanjing University of Chinese Medicine2 papers (2020–2021)Baihui Chen · Harbin Medical University2 papers (2022–2024)Ming Niu · Harbin Medical University2 papers (2017–2020)Dongxu Yang · University of Birmingham2 papers (2024–2025)Shanshan Sun · Shandong University2 papers (2017–2020)Youxue Zhang · Harbin Medical University2 papers (2020–2024)Shouping Xu · The First Affiliated Hospital, Sun Yat-sen University2 papers (2021–2025)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Oncology · Cancer Research →